• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Lamina-associated polypeptide 2, isoform alpha (TMPO)

ACP23630

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP23630 Target NameTMPO
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range2-694Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP42166
Background Information
  • Uniprot Id

    P42166

  • Target Species

    Human

  • Target Name

    TMPO

  • Target Full Name

    Lamina-associated polypeptide 2, isoform alpha

  • Target Function

    May be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. Plays an important role, together with LMNA, in the nuclear anchorage of RB1.; TP and TP5 may play a role in T-cell development and function. TP5 is an immunomodulating pentapeptide.

  • Target Subcellular Location

    Nucleus. Chromosome. Note=Expressed diffusely throughout the nucleus.

  • Target Protein Families

    LEM family

  • Target Tissue Specificity

    Expressed in many tissues. Most abundant in adult thymus and fetal liver.

  • Target Synonyms

    TMPO; LAP2Lamina-associated polypeptide 2; isoform alpha; Thymopoietin isoform alpha; TP alpha; Thymopoietin-related peptide isoform alpha; TPRP isoform alpha) [Cleaved into: Thymopoietin; TP; Splenin); Thymopentin; TP5)]

Inquire Recombinant Human Lamina-associated polypeptide 2, isoform alpha (TMPO) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification